Breaking News Instant updates and real-time market news.

KZR

Kezar Life Sciences

$16.50

(0.00%)

16:20
08/09/18
08/09
16:20
08/09/18
16:20

Kezar Life Sciences reports Q2 EPS ($3.31), consensus (53c)

"The second quarter of 2018 marked multiple milestones for Kezar as we continue to execute on our strategy of developing our first-in-class selective immunoproteasome inhibitor for patients with severe autoimmune diseases. Enrollment is underway in KZR-616-002, our Phase 1b/2 trial in lupus (SLE) and lupus nephritis (LN), with top-line results from the initial two cohorts of the Phase 1b expected in the first half of 2019," said John Fowler, CEO of Kezar. "We remain on track to initiate our first randomized trial in LN, an area of high unmet medical need, in 2019. Finally, during this quarter we added key members to our management team and completed our IPO, which strengthened our balance sheet and will enable us to initiate clinical trials in up to four additional autoimmune indications also beginning in 2019." Cash Position. Cash, cash equivalents and marketable securities totaled $118.4 million as of June 30, 2018, compared to $51.0 million as of December 31, 2017. The increase in cash, cash equivalents and marketable securities was primarily attributable to IPO proceeds, net of cash used by the Company in operations to advance its clinical stage programs as well as preclinical research and development.

KZR Kezar Life Sciences
$16.50

(0.00%)

07/16/18
WELS
07/16/18
INITIATION
Target $30
WELS
Outperform
Kezar Life Sciences initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started Kezar Life Sciences with an Outperform rating and $30 price target based on what he views as a highly leverageable platform and pipeline of novel immunoproteasome inhibitors for autoimmune disease, substantial validation from less selective approved proteasome inhibitors for cancer, proximity to proof-of-concept data in Systemic Lupus and Lupus Nephritis, and prospects for rapid expansion to other autoimmune diseases, including several that could support breakthrough designation and accelerated approval path.
07/16/18
COWN
07/16/18
INITIATION
COWN
Outperform
Kezar Life Sciences initiated with an Outperform at Cowen
Cowen analyst Phil Nadeau initiated Kezar Life Sciences with an Outperform rating as he expects the generation of shareholder value as its development progresses with its lupus drug candidate, KZR-616.
07/16/18
JEFF
07/16/18
INITIATION
Target $23
JEFF
Buy
Kezar Life Sciences initiated with a Buy at Jefferies
Jefferies started Kezar Life Sciences with a Buy rating and $23 price target.
07/16/18
JEFF
07/16/18
INITIATION
Target $23
JEFF
Buy
Jefferies starts Kezar Life Sciences with Buy rating, $23 target
Jefferies analyst Maury Raycroft initiated coverage of Kezar Life Sciences with a Buy rating and $23 price target. The company offers a straightforward story as KZR-616 is "de-risked," best-in-class and offers an "appealing market opportunity."

TODAY'S FREE FLY STORIES

VGK

The Vanguard FTSE Europe ETF

$49.43

0.195 (0.40%)

14:50
12/11/18
12/11
14:50
12/11/18
14:50
Options
Put buyer in Vanguard FTSE Europe ETF opens a defensive position »

Put buyer in Vanguard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$18.95

-0.57 (-2.92%)

14:49
12/11/18
12/11
14:49
12/11/18
14:49
Options
American Eagle options imply 17.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

14:47
12/11/18
12/11
14:47
12/11/18
14:47
Hot Stocks
Breaking Hot Stocks news story  »

Hercules Technology…

TSLA

Tesla

$368.57

3.375 (0.92%)

14:44
12/11/18
12/11
14:44
12/11/18
14:44
Periodicals
Tesla seeks $167 in suit against former employee Tripp, CNBC reports »

Tesla wants over $167M in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IGC

India Globalization Capital

$0.00

(0.00%)

, CANN

General Cannabis

$0.00

(0.00%)

14:43
12/11/18
12/11
14:43
12/11/18
14:43
Periodicals
NY Gov. Cuomo to introduce plan to legalize recreational marijuana, NY Post says »

New York Governor Andrew…

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$31.81

0.82 (2.65%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$12.69

-0.19 (-1.48%)

TLRY

Tilray

$93.40

-3.79 (-3.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.88

0.17 (2.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

QSR

Restaurant Brands

$52.82

-0.97 (-1.80%)

14:40
12/11/18
12/11
14:40
12/11/18
14:40
Options
Puts on the menu at Restaurant Brands International »

Puts on the menu at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CGC

Canopy Growth

$31.78

0.79 (2.55%)

14:39
12/11/18
12/11
14:39
12/11/18
14:39
Technical Analysis
Technical Take: Canopy Growth pops in later afternoon trading »

The shares have spiked in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CSCO

Cisco

$46.72

-0.14 (-0.30%)

, INTC

Intel

$47.16

-0.05 (-0.11%)

14:31
12/11/18
12/11
14:31
12/11/18
14:31
Periodicals
Cisco in talks to acquire chip company Luxtera, Bloomberg reports »

Cisco Systems (CSCO) is…

CSCO

Cisco

$46.72

-0.14 (-0.30%)

INTC

Intel

$47.16

-0.05 (-0.11%)

AVGO

Broadcom

$244.97

5.76 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

DUK

Duke Energy

$90.52

-0.03 (-0.03%)

14:18
12/11/18
12/11
14:18
12/11/18
14:18
Hot Stocks
Duke says 45,000 customers in Carolinas remain without power after storm »

Duke Energy said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/11/18
12/11
14:17
12/11/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBTYA

Liberty Global

$22.82

-0.84 (-3.55%)

, VOD

Vodafone

$20.08

-0.055 (-0.27%)

14:16
12/11/18
12/11
14:16
12/11/18
14:16
Hot Stocks
Liberty Global says 'always anticipated' second phase review from EC »

The European Commission…

LBTYA

Liberty Global

$22.82

-0.84 (-3.55%)

VOD

Vodafone

$20.08

-0.055 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/11/18
12/11
14:16
12/11/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$147.66

-4.32 (-2.84%)

, SFTBF

SoftBank

$0.00

(0.00%)

14:13
12/11/18
12/11
14:13
12/11/18
14:13
Hot Stocks
Nvidia near lows as SoftBank said to plan sale of stake »

Shares of Nvidia (NVDA)…

NVDA

Nvidia

$147.66

-4.32 (-2.84%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

NVDA

Nvidia

$147.60

-4.38 (-2.88%)

, SFTBF

SoftBank

$0.00

(0.00%)

14:11
12/11/18
12/11
14:11
12/11/18
14:11
Periodicals
Breaking Periodicals news story on Nvidia, SoftBank »

SoftBank planning sale of…

NVDA

Nvidia

$147.60

-4.38 (-2.88%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

CSCO

Cisco

$46.81

-0.05 (-0.11%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Periodicals
Breaking Periodicals news story on Cisco »

Cisco in talks to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

CORT

Corcept Therapeutics

$12.66

-0.32 (-2.47%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Hot Stocks
Corcept Therapeutics spikes in afternoon trading, jump 16% »

Corcept is up $2.04, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTV

Aptiv

$66.34

1.01 (1.55%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Hot Stocks
Aptiv CEO Kevin Clark purchases 11,310 shares of company stock »

Aptiv CEO Kevin Clark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$42.08

-1.14 (-2.64%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Options
Second day of short-term put buying in First Solar ahead of a company event »

Second day of short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BGG

Briggs & Stratton

$13.32

-0.32 (-2.35%)

14:05
12/11/18
12/11
14:05
12/11/18
14:05
Hot Stocks
Briggs & Stratton unit announces facility expansion for job site products »

Allmand Bros, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$66.32

0.42 (0.64%)

14:05
12/11/18
12/11
14:05
12/11/18
14:05
Options
XPO Logistics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$81.53

-0.93 (-1.13%)

, MCO

Moody's

$145.15

-0.75 (-0.51%)

13:55
12/11/18
12/11
13:55
12/11/18
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Financial…

COF

Capital One

$81.53

-0.93 (-1.13%)

MCO

Moody's

$145.15

-0.75 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

GE

General Electric

$6.78

-0.145 (-2.10%)

13:50
12/11/18
12/11
13:50
12/11/18
13:50
Options
Put spread in General Electric may adjust downside position »

Put spread in General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$82.62

1.19 (1.46%)

13:47
12/11/18
12/11
13:47
12/11/18
13:47
Upgrade
Kadant rating change  »

Kadant upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 20

    Dec

SHPG

Shire

$169.43

-0.69 (-0.41%)

13:39
12/11/18
12/11
13:39
12/11/18
13:39
Downgrade
Shire rating change  »

Shire downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

PVTL

Pivotal Software

$18.04

0.01 (0.06%)

, AEO

American Eagle

$19.20

-0.32 (-1.64%)

13:35
12/11/18
12/11
13:35
12/11/18
13:35
Earnings
Notable companies reporting after market close »

Notable companies…

PVTL

Pivotal Software

$18.04

0.01 (0.06%)

AEO

American Eagle

$19.20

-0.32 (-1.64%)

PLAY

Dave & Buster's

$51.20

-1.32 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.